Pharma & Healthcare
Global CXCR4 Antagonists Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1786
- Pages: 108
- Figures: 131
- Views: 19
CXCR4 antagonists are small-molecule which block the CXCR4 receptors and prevent their activation. Blocking the receptors stop the receptors' ligand, CXCL12, from binding which prevent downstream effects. CXCR4 antagonists are especially important for hindering cancer progression because one of the downstream effects initiated by CXCR4 receptor activation is cell movement which lead to tumor growth and metastasis in cancer patients. The CXCR4 receptor has been targeted by antagonistic substances, these antagonists have prospective use as therapeutic drug agents, and are currently under development in labs worldwide.
Market Analysis and Insights: Global CXCR4 Antagonists Market
The global CXCR4 Antagonists market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of CXCR4 Antagonists include Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics and Harmonic Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
CXCR4 Antagonists is widely used in various fields, such as Cancer, HIV and Chronic Inflammatory Diseases,, etc. Cancer provides greatest supports to the CXCR4 Antagonists industry development. In 2023, global % revenue of CXCR4 Antagonists went into Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for CXCR4 Antagonists market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of CXCR4 Antagonists, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CXCR4 Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CXCR4 Antagonists revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CXCR4 Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CXCR4 Antagonists revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories
Segment by Type
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others
Segment by Application
Cancer
HIV
Chronic Inflammatory Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CXCR4 Antagonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CXCR4 Antagonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CXCR4 Antagonists revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global CXCR4 Antagonists Market
The global CXCR4 Antagonists market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for CXCR4 Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of CXCR4 Antagonists include Sanofi, BioLineRx, X4 Pharmaceuticals, Eli Lilly, Roche, Merck, Biokine Therapeutics, GlycoMimetics and Harmonic Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
CXCR4 Antagonists is widely used in various fields, such as Cancer, HIV and Chronic Inflammatory Diseases,, etc. Cancer provides greatest supports to the CXCR4 Antagonists industry development. In 2023, global % revenue of CXCR4 Antagonists went into Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for CXCR4 Antagonists market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of CXCR4 Antagonists, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CXCR4 Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CXCR4 Antagonists revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CXCR4 Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CXCR4 Antagonists revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories
Segment by Type
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others
Segment by Application
Cancer
HIV
Chronic Inflammatory Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CXCR4 Antagonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CXCR4 Antagonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CXCR4 Antagonists revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 BL-8040
1.2.3 GMI-1359
1.2.4 Plerixafor (AMD3100)
1.2.5 Balixafortide (POL6326)
1.2.6 USL311
1.2.7 Others
1.3 Market by Application
1.3.1 Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 HIV
1.3.4 Chronic Inflammatory Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CXCR4 Antagonists Market Perspective (2019-2030)
2.2 Global CXCR4 Antagonists Growth Trends by Region
2.2.1 CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CXCR4 Antagonists Historic Market Size by Region (2019-2024)
2.2.3 CXCR4 Antagonists Forecasted Market Size by Region (2025-2030)
2.3 CXCR4 Antagonists Market Dynamics
2.3.1 CXCR4 Antagonists Industry Trends
2.3.2 CXCR4 Antagonists Market Drivers
2.3.3 CXCR4 Antagonists Market Challenges
2.3.4 CXCR4 Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CXCR4 Antagonists by Players
3.1.1 Global CXCR4 Antagonists Revenue by Players (2019-2024)
3.1.2 Global CXCR4 Antagonists Revenue Market Share by Players (2019-2024)
3.2 Global CXCR4 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CXCR4 Antagonists, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global CXCR4 Antagonists Market Concentration Ratio
3.4.1 Global CXCR4 Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CXCR4 Antagonists Revenue in 2023
3.5 Global Key Players of CXCR4 Antagonists Head office and Area Served
3.6 Global Key Players of CXCR4 Antagonists, Product and Application
3.7 Global Key Players of CXCR4 Antagonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CXCR4 Antagonists Breakdown Data by Type
4.1 Global CXCR4 Antagonists Historic Market Size by Type (2019-2024)
4.2 Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030)
5 CXCR4 Antagonists Breakdown Data by Application
5.1 Global CXCR4 Antagonists Historic Market Size by Application (2019-2024)
5.2 Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CXCR4 Antagonists Market Size (2019-2030)
6.2 North America CXCR4 Antagonists Market Size by Type
6.2.1 North America CXCR4 Antagonists Market Size by Type (2019-2024)
6.2.2 North America CXCR4 Antagonists Market Size by Type (2025-2030)
6.2.3 North America CXCR4 Antagonists Market Share by Type (2019-2030)
6.3 North America CXCR4 Antagonists Market Size by Application
6.3.1 North America CXCR4 Antagonists Market Size by Application (2019-2024)
6.3.2 North America CXCR4 Antagonists Market Size by Application (2025-2030)
6.3.3 North America CXCR4 Antagonists Market Share by Application (2019-2030)
6.4 North America CXCR4 Antagonists Market Size by Country
6.4.1 North America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America CXCR4 Antagonists Market Size by Country (2019-2024)
6.4.3 North America CXCR4 Antagonists Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe CXCR4 Antagonists Market Size (2019-2030)
7.2 Europe CXCR4 Antagonists Market Size by Type
7.2.1 Europe CXCR4 Antagonists Market Size by Type (2019-2024)
7.2.2 Europe CXCR4 Antagonists Market Size by Type (2025-2030)
7.2.3 Europe CXCR4 Antagonists Market Share by Type (2019-2030)
7.3 Europe CXCR4 Antagonists Market Size by Application
7.3.1 Europe CXCR4 Antagonists Market Size by Application (2019-2024)
7.3.2 Europe CXCR4 Antagonists Market Size by Application (2025-2030)
7.3.3 Europe CXCR4 Antagonists Market Share by Application (2019-2030)
7.4 Europe CXCR4 Antagonists Market Size by Country
7.4.1 Europe CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe CXCR4 Antagonists Market Size by Country (2019-2024)
7.4.3 Europe CXCR4 Antagonists Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CXCR4 Antagonists Market Size (2019-2030)
8.2 China CXCR4 Antagonists Market Size by Type
8.2.1 China CXCR4 Antagonists Market Size by Type (2019-2024)
8.2.2 China CXCR4 Antagonists Market Size by Type (2025-2030)
8.2.3 China CXCR4 Antagonists Market Share by Type (2019-2030)
8.3 China CXCR4 Antagonists Market Size by Application
8.3.1 China CXCR4 Antagonists Market Size by Application (2019-2024)
8.3.2 China CXCR4 Antagonists Market Size by Application (2025-2030)
8.3.3 China CXCR4 Antagonists Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia CXCR4 Antagonists Market Size (2019-2030)
9.2 Asia CXCR4 Antagonists Market Size by Type
9.2.1 Asia CXCR4 Antagonists Market Size by Type (2019-2024)
9.2.2 Asia CXCR4 Antagonists Market Size by Type (2025-2030)
9.2.3 Asia CXCR4 Antagonists Market Share by Type (2019-2030)
9.3 Asia CXCR4 Antagonists Market Size by Application
9.3.1 Asia CXCR4 Antagonists Market Size by Application (2019-2024)
9.3.2 Asia CXCR4 Antagonists Market Size by Application (2025-2030)
9.3.3 Asia CXCR4 Antagonists Market Share by Application (2019-2030)
9.4 Asia CXCR4 Antagonists Market Size by Region
9.4.1 Asia CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia CXCR4 Antagonists Market Size by Region (2019-2024)
9.4.3 Asia CXCR4 Antagonists Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type
10.2.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application
10.3.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country
10.4.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi CXCR4 Antagonists Introduction
11.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2019-2024)
11.1.5 Sanofi Recent Developments
11.2 BioLineRx
11.2.1 BioLineRx Company Details
11.2.2 BioLineRx Business Overview
11.2.3 BioLineRx CXCR4 Antagonists Introduction
11.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024)
11.2.5 BioLineRx Recent Developments
11.3 X4 Pharmaceuticals
11.3.1 X4 Pharmaceuticals Company Details
11.3.2 X4 Pharmaceuticals Business Overview
11.3.3 X4 Pharmaceuticals CXCR4 Antagonists Introduction
11.3.4 X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024)
11.3.5 X4 Pharmaceuticals Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly CXCR4 Antagonists Introduction
11.4.4 Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche CXCR4 Antagonists Introduction
11.5.4 Roche Revenue in CXCR4 Antagonists Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck CXCR4 Antagonists Introduction
11.6.4 Merck Revenue in CXCR4 Antagonists Business (2019-2024)
11.6.5 Merck Recent Developments
11.7 Biokine Therapeutics
11.7.1 Biokine Therapeutics Company Details
11.7.2 Biokine Therapeutics Business Overview
11.7.3 Biokine Therapeutics CXCR4 Antagonists Introduction
11.7.4 Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024)
11.7.5 Biokine Therapeutics Recent Developments
11.8 GlycoMimetics
11.8.1 GlycoMimetics Company Details
11.8.2 GlycoMimetics Business Overview
11.8.3 GlycoMimetics CXCR4 Antagonists Introduction
11.8.4 GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024)
11.8.5 GlycoMimetics Recent Developments
11.9 Harmonic Pharma
11.9.1 Harmonic Pharma Company Details
11.9.2 Harmonic Pharma Business Overview
11.9.3 Harmonic Pharma CXCR4 Antagonists Introduction
11.9.4 Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024)
11.9.5 Harmonic Pharma Recent Developments
11.10 Upsher-Smith Laboratories
11.10.1 Upsher-Smith Laboratories Company Details
11.10.2 Upsher-Smith Laboratories Business Overview
11.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Introduction
11.10.4 Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024)
11.10.5 Upsher-Smith Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 BL-8040
1.2.3 GMI-1359
1.2.4 Plerixafor (AMD3100)
1.2.5 Balixafortide (POL6326)
1.2.6 USL311
1.2.7 Others
1.3 Market by Application
1.3.1 Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 HIV
1.3.4 Chronic Inflammatory Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CXCR4 Antagonists Market Perspective (2019-2030)
2.2 Global CXCR4 Antagonists Growth Trends by Region
2.2.1 CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CXCR4 Antagonists Historic Market Size by Region (2019-2024)
2.2.3 CXCR4 Antagonists Forecasted Market Size by Region (2025-2030)
2.3 CXCR4 Antagonists Market Dynamics
2.3.1 CXCR4 Antagonists Industry Trends
2.3.2 CXCR4 Antagonists Market Drivers
2.3.3 CXCR4 Antagonists Market Challenges
2.3.4 CXCR4 Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CXCR4 Antagonists by Players
3.1.1 Global CXCR4 Antagonists Revenue by Players (2019-2024)
3.1.2 Global CXCR4 Antagonists Revenue Market Share by Players (2019-2024)
3.2 Global CXCR4 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CXCR4 Antagonists, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global CXCR4 Antagonists Market Concentration Ratio
3.4.1 Global CXCR4 Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CXCR4 Antagonists Revenue in 2023
3.5 Global Key Players of CXCR4 Antagonists Head office and Area Served
3.6 Global Key Players of CXCR4 Antagonists, Product and Application
3.7 Global Key Players of CXCR4 Antagonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CXCR4 Antagonists Breakdown Data by Type
4.1 Global CXCR4 Antagonists Historic Market Size by Type (2019-2024)
4.2 Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030)
5 CXCR4 Antagonists Breakdown Data by Application
5.1 Global CXCR4 Antagonists Historic Market Size by Application (2019-2024)
5.2 Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CXCR4 Antagonists Market Size (2019-2030)
6.2 North America CXCR4 Antagonists Market Size by Type
6.2.1 North America CXCR4 Antagonists Market Size by Type (2019-2024)
6.2.2 North America CXCR4 Antagonists Market Size by Type (2025-2030)
6.2.3 North America CXCR4 Antagonists Market Share by Type (2019-2030)
6.3 North America CXCR4 Antagonists Market Size by Application
6.3.1 North America CXCR4 Antagonists Market Size by Application (2019-2024)
6.3.2 North America CXCR4 Antagonists Market Size by Application (2025-2030)
6.3.3 North America CXCR4 Antagonists Market Share by Application (2019-2030)
6.4 North America CXCR4 Antagonists Market Size by Country
6.4.1 North America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America CXCR4 Antagonists Market Size by Country (2019-2024)
6.4.3 North America CXCR4 Antagonists Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe CXCR4 Antagonists Market Size (2019-2030)
7.2 Europe CXCR4 Antagonists Market Size by Type
7.2.1 Europe CXCR4 Antagonists Market Size by Type (2019-2024)
7.2.2 Europe CXCR4 Antagonists Market Size by Type (2025-2030)
7.2.3 Europe CXCR4 Antagonists Market Share by Type (2019-2030)
7.3 Europe CXCR4 Antagonists Market Size by Application
7.3.1 Europe CXCR4 Antagonists Market Size by Application (2019-2024)
7.3.2 Europe CXCR4 Antagonists Market Size by Application (2025-2030)
7.3.3 Europe CXCR4 Antagonists Market Share by Application (2019-2030)
7.4 Europe CXCR4 Antagonists Market Size by Country
7.4.1 Europe CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe CXCR4 Antagonists Market Size by Country (2019-2024)
7.4.3 Europe CXCR4 Antagonists Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CXCR4 Antagonists Market Size (2019-2030)
8.2 China CXCR4 Antagonists Market Size by Type
8.2.1 China CXCR4 Antagonists Market Size by Type (2019-2024)
8.2.2 China CXCR4 Antagonists Market Size by Type (2025-2030)
8.2.3 China CXCR4 Antagonists Market Share by Type (2019-2030)
8.3 China CXCR4 Antagonists Market Size by Application
8.3.1 China CXCR4 Antagonists Market Size by Application (2019-2024)
8.3.2 China CXCR4 Antagonists Market Size by Application (2025-2030)
8.3.3 China CXCR4 Antagonists Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia CXCR4 Antagonists Market Size (2019-2030)
9.2 Asia CXCR4 Antagonists Market Size by Type
9.2.1 Asia CXCR4 Antagonists Market Size by Type (2019-2024)
9.2.2 Asia CXCR4 Antagonists Market Size by Type (2025-2030)
9.2.3 Asia CXCR4 Antagonists Market Share by Type (2019-2030)
9.3 Asia CXCR4 Antagonists Market Size by Application
9.3.1 Asia CXCR4 Antagonists Market Size by Application (2019-2024)
9.3.2 Asia CXCR4 Antagonists Market Size by Application (2025-2030)
9.3.3 Asia CXCR4 Antagonists Market Share by Application (2019-2030)
9.4 Asia CXCR4 Antagonists Market Size by Region
9.4.1 Asia CXCR4 Antagonists Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia CXCR4 Antagonists Market Size by Region (2019-2024)
9.4.3 Asia CXCR4 Antagonists Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type
10.2.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application
10.3.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country
10.4.1 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi CXCR4 Antagonists Introduction
11.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2019-2024)
11.1.5 Sanofi Recent Developments
11.2 BioLineRx
11.2.1 BioLineRx Company Details
11.2.2 BioLineRx Business Overview
11.2.3 BioLineRx CXCR4 Antagonists Introduction
11.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024)
11.2.5 BioLineRx Recent Developments
11.3 X4 Pharmaceuticals
11.3.1 X4 Pharmaceuticals Company Details
11.3.2 X4 Pharmaceuticals Business Overview
11.3.3 X4 Pharmaceuticals CXCR4 Antagonists Introduction
11.3.4 X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024)
11.3.5 X4 Pharmaceuticals Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly CXCR4 Antagonists Introduction
11.4.4 Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche CXCR4 Antagonists Introduction
11.5.4 Roche Revenue in CXCR4 Antagonists Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck CXCR4 Antagonists Introduction
11.6.4 Merck Revenue in CXCR4 Antagonists Business (2019-2024)
11.6.5 Merck Recent Developments
11.7 Biokine Therapeutics
11.7.1 Biokine Therapeutics Company Details
11.7.2 Biokine Therapeutics Business Overview
11.7.3 Biokine Therapeutics CXCR4 Antagonists Introduction
11.7.4 Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024)
11.7.5 Biokine Therapeutics Recent Developments
11.8 GlycoMimetics
11.8.1 GlycoMimetics Company Details
11.8.2 GlycoMimetics Business Overview
11.8.3 GlycoMimetics CXCR4 Antagonists Introduction
11.8.4 GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024)
11.8.5 GlycoMimetics Recent Developments
11.9 Harmonic Pharma
11.9.1 Harmonic Pharma Company Details
11.9.2 Harmonic Pharma Business Overview
11.9.3 Harmonic Pharma CXCR4 Antagonists Introduction
11.9.4 Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024)
11.9.5 Harmonic Pharma Recent Developments
11.10 Upsher-Smith Laboratories
11.10.1 Upsher-Smith Laboratories Company Details
11.10.2 Upsher-Smith Laboratories Business Overview
11.10.3 Upsher-Smith Laboratories CXCR4 Antagonists Introduction
11.10.4 Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024)
11.10.5 Upsher-Smith Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CXCR4 Antagonists Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of BL-8040
Table 3. Key Players of GMI-1359
Table 4. Key Players of Plerixafor (AMD3100)
Table 5. Key Players of Balixafortide (POL6326)
Table 6. Key Players of USL311
Table 7. Key Players of Others
Table 8. Global CXCR4 Antagonists Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Global CXCR4 Antagonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global CXCR4 Antagonists Market Share by Region (2019-2024)
Table 12. Global CXCR4 Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global CXCR4 Antagonists Market Share by Region (2025-2030)
Table 14. CXCR4 Antagonists Market Trends
Table 15. CXCR4 Antagonists Market Drivers
Table 16. CXCR4 Antagonists Market Challenges
Table 17. CXCR4 Antagonists Market Restraints
Table 18. Global CXCR4 Antagonists Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global CXCR4 Antagonists Revenue Share by Players (2019-2024)
Table 20. Global Top CXCR4 Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)
Table 21. Global CXCR4 Antagonists Industry Ranking 2022 VS 2023 VS 2024
Table 22. Global 5 Largest Players Market Share by CXCR4 Antagonists Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of CXCR4 Antagonists, Headquarters and Area Served
Table 24. Global Key Players of CXCR4 Antagonists, Product and Application
Table 25. Global Key Players of CXCR4 Antagonists, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global CXCR4 Antagonists Revenue Market Share by Type (2019-2024)
Table 29. Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global CXCR4 Antagonists Revenue Market Share by Type (2025-2030)
Table 31. Global CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global CXCR4 Antagonists Revenue Share by Application (2019-2024)
Table 33. Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global CXCR4 Antagonists Revenue Share by Application (2025-2030)
Table 35. North America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 36. North America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 37. North America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 38. North America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 39. North America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 43. Europe CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 44. Europe CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 45. Europe CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 46. Europe CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Europe CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 48. Europe CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 49. China CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 50. China CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 51. China CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 52. China CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 54. Asia CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 55. Asia CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 56. Asia CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 57. Asia CXCR4 Antagonists Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 58. Asia CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 59. Asia CXCR4 Antagonists Market Size by Region (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 64. Middle East, Africa, and Latin America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 65. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi CXCR4 Antagonists Product
Table 70. Sanofi Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 71. Sanofi Recent Developments
Table 72. BioLineRx Company Details
Table 73. BioLineRx Business Overview
Table 74. BioLineRx CXCR4 Antagonists Product
Table 75. BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 76. BioLineRx Recent Developments
Table 77. X4 Pharmaceuticals Company Details
Table 78. X4 Pharmaceuticals Business Overview
Table 79. X4 Pharmaceuticals CXCR4 Antagonists Product
Table 80. X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 81. X4 Pharmaceuticals Recent Developments
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly CXCR4 Antagonists Product
Table 85. Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 86. Eli Lilly Recent Developments
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche CXCR4 Antagonists Product
Table 90. Roche Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 91. Roche Recent Developments
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck CXCR4 Antagonists Product
Table 95. Merck Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 96. Merck Recent Developments
Table 97. Biokine Therapeutics Company Details
Table 98. Biokine Therapeutics Business Overview
Table 99. Biokine Therapeutics CXCR4 Antagonists Product
Table 100. Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 101. Biokine Therapeutics Recent Developments
Table 102. GlycoMimetics Company Details
Table 103. GlycoMimetics Business Overview
Table 104. GlycoMimetics CXCR4 Antagonists Product
Table 105. GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 106. GlycoMimetics Recent Developments
Table 107. Harmonic Pharma Company Details
Table 108. Harmonic Pharma Business Overview
Table 109. Harmonic Pharma CXCR4 Antagonists Product
Table 110. Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 111. Harmonic Pharma Recent Developments
Table 112. Upsher-Smith Laboratories Company Details
Table 113. Upsher-Smith Laboratories Business Overview
Table 114. Upsher-Smith Laboratories CXCR4 Antagonists Product
Table 115. Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 116. Upsher-Smith Laboratories Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global CXCR4 Antagonists Market Share by Type: 2023 VS 2030
Figure 3. BL-8040 Features
Figure 4. GMI-1359 Features
Figure 5. Plerixafor (AMD3100) Features
Figure 6. Balixafortide (POL6326) Features
Figure 7. USL311 Features
Figure 8. Others Features
Figure 9. Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global CXCR4 Antagonists Market Share by Application: 2023 VS 2030
Figure 11. Cancer Case Studies
Figure 12. HIV Case Studies
Figure 13. Chronic Inflammatory Diseases Case Studies
Figure 14. CXCR4 Antagonists Report Years Considered
Figure 15. Global CXCR4 Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global CXCR4 Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global CXCR4 Antagonists Market Share by Region: 2023 VS 2030
Figure 18. Global CXCR4 Antagonists Market Share by Players in 2023
Figure 19. Global Top CXCR4 Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by CXCR4 Antagonists Revenue in 2023
Figure 21. North America CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 23. North America CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 24. North America CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 25. United States CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 28. Europe CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 29. Europe CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 30. Europe CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 31. Germany CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. China CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 38. China CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 39. China CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 40. Asia CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 41. Asia CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 42. Asia CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 43. Asia CXCR4 Antagonists Market Share by Region (2019-2030)
Figure 44. Japan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. South Korea CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Taiwan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Southeast Asia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. India CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Australia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 52. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 53. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 54. Brazil CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Mexico CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Turkey CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Israel CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. GCC Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 61. BioLineRx Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 62. X4 Pharmaceuticals Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 63. Eli Lilly Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 64. Roche Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 65. Merck Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 66. Biokine Therapeutics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 67. GlycoMimetics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 68. Harmonic Pharma Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 69. Upsher-Smith Laboratories Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global CXCR4 Antagonists Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of BL-8040
Table 3. Key Players of GMI-1359
Table 4. Key Players of Plerixafor (AMD3100)
Table 5. Key Players of Balixafortide (POL6326)
Table 6. Key Players of USL311
Table 7. Key Players of Others
Table 8. Global CXCR4 Antagonists Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Global CXCR4 Antagonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global CXCR4 Antagonists Market Share by Region (2019-2024)
Table 12. Global CXCR4 Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global CXCR4 Antagonists Market Share by Region (2025-2030)
Table 14. CXCR4 Antagonists Market Trends
Table 15. CXCR4 Antagonists Market Drivers
Table 16. CXCR4 Antagonists Market Challenges
Table 17. CXCR4 Antagonists Market Restraints
Table 18. Global CXCR4 Antagonists Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global CXCR4 Antagonists Revenue Share by Players (2019-2024)
Table 20. Global Top CXCR4 Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)
Table 21. Global CXCR4 Antagonists Industry Ranking 2022 VS 2023 VS 2024
Table 22. Global 5 Largest Players Market Share by CXCR4 Antagonists Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of CXCR4 Antagonists, Headquarters and Area Served
Table 24. Global Key Players of CXCR4 Antagonists, Product and Application
Table 25. Global Key Players of CXCR4 Antagonists, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global CXCR4 Antagonists Revenue Market Share by Type (2019-2024)
Table 29. Global CXCR4 Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global CXCR4 Antagonists Revenue Market Share by Type (2025-2030)
Table 31. Global CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global CXCR4 Antagonists Revenue Share by Application (2019-2024)
Table 33. Global CXCR4 Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global CXCR4 Antagonists Revenue Share by Application (2025-2030)
Table 35. North America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 36. North America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 37. North America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 38. North America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 39. North America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 43. Europe CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 44. Europe CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 45. Europe CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 46. Europe CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Europe CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 48. Europe CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 49. China CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 50. China CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 51. China CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 52. China CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 54. Asia CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 55. Asia CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 56. Asia CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 57. Asia CXCR4 Antagonists Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 58. Asia CXCR4 Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 59. Asia CXCR4 Antagonists Market Size by Region (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 64. Middle East, Africa, and Latin America CXCR4 Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 65. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi CXCR4 Antagonists Product
Table 70. Sanofi Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 71. Sanofi Recent Developments
Table 72. BioLineRx Company Details
Table 73. BioLineRx Business Overview
Table 74. BioLineRx CXCR4 Antagonists Product
Table 75. BioLineRx Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 76. BioLineRx Recent Developments
Table 77. X4 Pharmaceuticals Company Details
Table 78. X4 Pharmaceuticals Business Overview
Table 79. X4 Pharmaceuticals CXCR4 Antagonists Product
Table 80. X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 81. X4 Pharmaceuticals Recent Developments
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly CXCR4 Antagonists Product
Table 85. Eli Lilly Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 86. Eli Lilly Recent Developments
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche CXCR4 Antagonists Product
Table 90. Roche Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 91. Roche Recent Developments
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck CXCR4 Antagonists Product
Table 95. Merck Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 96. Merck Recent Developments
Table 97. Biokine Therapeutics Company Details
Table 98. Biokine Therapeutics Business Overview
Table 99. Biokine Therapeutics CXCR4 Antagonists Product
Table 100. Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 101. Biokine Therapeutics Recent Developments
Table 102. GlycoMimetics Company Details
Table 103. GlycoMimetics Business Overview
Table 104. GlycoMimetics CXCR4 Antagonists Product
Table 105. GlycoMimetics Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 106. GlycoMimetics Recent Developments
Table 107. Harmonic Pharma Company Details
Table 108. Harmonic Pharma Business Overview
Table 109. Harmonic Pharma CXCR4 Antagonists Product
Table 110. Harmonic Pharma Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 111. Harmonic Pharma Recent Developments
Table 112. Upsher-Smith Laboratories Company Details
Table 113. Upsher-Smith Laboratories Business Overview
Table 114. Upsher-Smith Laboratories CXCR4 Antagonists Product
Table 115. Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2019-2024) & (US$ Million)
Table 116. Upsher-Smith Laboratories Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CXCR4 Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global CXCR4 Antagonists Market Share by Type: 2023 VS 2030
Figure 3. BL-8040 Features
Figure 4. GMI-1359 Features
Figure 5. Plerixafor (AMD3100) Features
Figure 6. Balixafortide (POL6326) Features
Figure 7. USL311 Features
Figure 8. Others Features
Figure 9. Global CXCR4 Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global CXCR4 Antagonists Market Share by Application: 2023 VS 2030
Figure 11. Cancer Case Studies
Figure 12. HIV Case Studies
Figure 13. Chronic Inflammatory Diseases Case Studies
Figure 14. CXCR4 Antagonists Report Years Considered
Figure 15. Global CXCR4 Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global CXCR4 Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global CXCR4 Antagonists Market Share by Region: 2023 VS 2030
Figure 18. Global CXCR4 Antagonists Market Share by Players in 2023
Figure 19. Global Top CXCR4 Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CXCR4 Antagonists as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by CXCR4 Antagonists Revenue in 2023
Figure 21. North America CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 23. North America CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 24. North America CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 25. United States CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 28. Europe CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 29. Europe CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 30. Europe CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 31. Germany CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. China CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 38. China CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 39. China CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 40. Asia CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 41. Asia CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 42. Asia CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 43. Asia CXCR4 Antagonists Market Share by Region (2019-2030)
Figure 44. Japan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. South Korea CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Taiwan CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Southeast Asia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. India CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Australia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America CXCR4 Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Type (2019-2030)
Figure 52. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Application (2019-2030)
Figure 53. Middle East, Africa, and Latin America CXCR4 Antagonists Market Share by Country (2019-2030)
Figure 54. Brazil CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Mexico CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Turkey CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Israel CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. GCC Countries CXCR4 Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Sanofi Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 61. BioLineRx Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 62. X4 Pharmaceuticals Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 63. Eli Lilly Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 64. Roche Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 65. Merck Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 66. Biokine Therapeutics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 67. GlycoMimetics Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 68. Harmonic Pharma Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 69. Upsher-Smith Laboratories Revenue Growth Rate in CXCR4 Antagonists Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232